Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
Daiichi Sankyo
Citi
Chinese Patent Office
Covington
Baxter
Express Scripts
Moodys

Generated: May 27, 2018

DrugPatentWatch Database Preview

NEBUPENT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Nebupent patents expire, and what generic alternatives are available?

Nebupent is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in NEBUPENT is pentamidine isethionate. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
Drug patent expirations by year for NEBUPENT
Pharmacology for NEBUPENT
Drug ClassAntiprotozoal
Medical Subject Heading (MeSH) Categories for NEBUPENT
Synonyms for NEBUPENT
[pentane-1,5-diylbis(oxy-4,1-phenylene)]bis(aminomethaniminium) bis(2-hydroxyethanesulfonate)
1,5-Bis(p-amidinophenoxy)pentane bis(2-hydroxyethanesulfonate salt)
1,5-bis[p-amidinophenoxy]pentane bis[2-hydroxyethanesulfonate salt] isethionate salt
140-64-7
140P647
2512 R.P.
4-[5-(4-amidinophenoxy)pentyloxy]benzenecarboxamidine, 2-hydroxyethanesulfonic acid, 2-hydroxyethanesulfonic acid
4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid
4,4 inverted exclamation marka-(Pentamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulfonate)
4,4'-(Pentamethylenedioxy)-dibenzamidine bis(2-hydroxyethanesulfonate)
4,4'-(pentamethylenedioxy)dibenzamide bis(2-hydroxyethanesulfonate)
4,4'-(Pentamethylenedioxy)dibenzamidine bis-2-hydroxyethanesulfonate salt
4,4'-(pentamethylenedioxy)dibenzamidine bis(2-hyd
4,4'-(Pentamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulfonate)
4,4'-(pentamethylenedioxy)dibenzamidine, bis-2-hydroxyethanesulfonate
4,4'-(pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethane-1-sulfonate)
4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate)
4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate);4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate)
4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide bis(2-hydroxyethanesulfonic acid)
4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide bis(2-hydroxyethylsulfonate)
4,4'-diamidino-a,w-diphenoxypentane isethionate
4,4'-Diamidino-alpha,omega-diphenoxypentane isethionate
4,4'-Diamidinodiphenoxypentane di(beta-hydroxyethanesulfonate)
4CH-018037
AB0015398
AC1L1RR1
AC1Q6X9Y
AK-51766
AKOS015914189
ANW-48586
API0003784
AX8027505
BC221820
Benzamidine, 4,4'-(pentamethylenedioxy)di-, bis(beta-hydroxyethanesulfonate)
bis(2-hydroxyethane-1-sulfonic acid); 4-{[5-(4-carbamimidoylphenoxy)pentyl]oxy}benzene-1-carboximidamide
BR-51766
C-23299
C23H36N4O10S2
CAS-140-64-7
CCG-39715
CCRIS 1660
CHEBI:7977
CHEMBL361506
CS-4133
CTK8B5397
D00834
DSSTox_CID_3796
DSSTox_GSID_23796
DSSTox_RID_77194
DTXSID5023796
EINECS 205-424-1
Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4'-(1,5-pentanediylbis(oxy))bis(benzenecarboximidamide) (2:1)
FT-0631814
HMS1569P07
HMS1921M19
HMS2096P07
HMS501D11
HY-B0537B
I14-45109
KS-00000Z9I
KS-5289
Lomidine
M808
MCULE-6357662093
MFCD00079213
MolPort-003-665-497
NCGC00017022-01
NCGC00017022-02
NCGC00017022-03
NCGC00017022-04
NCGC00017022-05
NCGC00091927-01
NCGC00091927-02
NCGC00091927-03
NCGC00091927-04
NCGC00179034-07
NCGC00254121-01
NCGC00259271-01
OR008871
p,p'-(Pentamethylenedioxy)dibenzamidine bis(beta-hydroxyethanesulfonate)
Pentacarinat
PENTAM
Pentam 300
Pentam 300 (TN)
Pentamidin-Isethionat
Pentamidine (isethionate)
Pentamidine diisethionate
Pentamidine diisetionate
Pentamidine diisetionate, European Pharmacopoeia (EP) Reference Standard
PENTAMIDINE ISETHIONATE
Pentamidine isethionate (USAN)
Pentamidine isethionate [USAN:USP]
Pentamidine isethionate salt
Pentamidine isethionate salt, powder
Pentamidine isethionate, United States Pharmacopeia (USP) Reference Standard
Pentamidine isetionate
Pentamidine isetionate (JAN)
PENTAMIDINE; BIS(SODIUM ISETHIONATE)
Pentaminide isetionate
Pneumopent
Prestwick_857
PubChem20964
S-3112
SCHEMBL33615
SPECTRUM1500641
SR-01000075174
SR-01000075174-1
ST2407516
ST51006692
TC-137331
Tox21_110742
Tox21_110742_1
Tox21_201722
Tox21_300312
UNII-V2P3K60DA2
USAF XR-10
V2P3K60DA2
W-108199
Z1558572531

US Patents and Regulatory Information for NEBUPENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa NEBUPENT pentamidine isethionate FOR SOLUTION;INHALATION 019887-001 Jun 15, 1989 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NEBUPENT pentamidine isethionate FOR SOLUTION;INHALATION 019887-002 Mar 22, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Colorcon
US Army
Moodys
Queensland Health
Argus Health
Teva
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.